Nanoparticle-Based Combination Therapy for Melanoma
- PMID: 35837089
- PMCID: PMC9273962
- DOI: 10.3389/fonc.2022.928797
Nanoparticle-Based Combination Therapy for Melanoma
Abstract
Melanoma is a cutaneous carcinoma, and its incidence is rapidly increasing with every year. The treatment options for melanoma have been comprehensively studied. Conventional treatment methods (e.g., radiotherapy, chemotherapy and photodynamic therapy) with surgical removal inevitably cause serious complications; moreover, resistance is common. Nanoparticles (NPs) combined with conventional methods are new and promising options to treat melanoma, and many combinations have been achieving good success. Due to their physical and biological features, NPs can help target intended melanoma cells more efficiently with less damage. This creates new hope for a better treatment strategy for melanoma with minimum damage and maximum efficacy.
Keywords: chemotherapy; combined therapy; immunotherapy; melanoma; nanoparticles; photodynamic therapy.
Copyright © 2022 Chen, Hou, Yu, Wang and Chen.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Dual Encapsulated Dacarbazine and Zinc Phthalocyanine Polymeric Nanoparticle for Photodynamic Therapy of Melanoma.Pharm Res. 2021 Feb;38(2):335-346. doi: 10.1007/s11095-021-02999-w. Epub 2021 Feb 18. Pharm Res. 2021. PMID: 33604784
-
Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.J Transl Med. 2016 Nov 15;14(1):313. doi: 10.1186/s12967-016-1070-y. J Transl Med. 2016. PMID: 27846884 Free PMC article.
-
Advances in Photodynamic Therapy Based on Nanotechnology and Its Application in Skin Cancer.Front Oncol. 2022 Mar 16;12:836397. doi: 10.3389/fonc.2022.836397. eCollection 2022. Front Oncol. 2022. PMID: 35372087 Free PMC article. Review.
-
Targeted delivery and enhanced uptake of chemo-photodynamic nanomedicine for melanoma treatment.Acta Biomater. 2022 Jul 15;147:356-365. doi: 10.1016/j.actbio.2022.05.015. Epub 2022 May 14. Acta Biomater. 2022. PMID: 35577046
-
Photodynamic therapy in treatment of cutaneous and choroidal melanoma.Photodiagnosis Photodyn Ther. 2013 Dec;10(4):503-9. doi: 10.1016/j.pdpdt.2013.05.006. Epub 2013 Jun 17. Photodiagnosis Photodyn Ther. 2013. PMID: 24284103 Review.
Cited by
-
Applications and challenges of photodynamic therapy in the treatment of skin malignancies.Front Pharmacol. 2024 Sep 19;15:1476228. doi: 10.3389/fphar.2024.1476228. eCollection 2024. Front Pharmacol. 2024. PMID: 39364058 Free PMC article. Review.
-
Molecular Frontiers in Melanoma: Pathogenesis, Diagnosis, and Therapeutic Advances.Int J Mol Sci. 2024 Mar 4;25(5):2984. doi: 10.3390/ijms25052984. Int J Mol Sci. 2024. PMID: 38474231 Free PMC article. Review.
-
Immunotherapy and delivery systems for melanoma.Hum Vaccin Immunother. 2024 Dec 31;20(1):2394252. doi: 10.1080/21645515.2024.2394252. Epub 2024 Sep 17. Hum Vaccin Immunother. 2024. PMID: 39286868 Free PMC article. Review.
-
Advances in mechanisms and challenges in clinical translation of synergistic nanomaterial-based therapies for melanoma.Front Cell Dev Biol. 2025 Jul 25;13:1648379. doi: 10.3389/fcell.2025.1648379. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40787624 Free PMC article. Review.
-
Exploiting the potential of extracellular vesicles as delivery vehicles for the treatment of melanoma.Front Bioeng Biotechnol. 2022 Nov 17;10:1054324. doi: 10.3389/fbioe.2022.1054324. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36466338 Free PMC article. Review.
References
-
- Pavlotsky F, Azizi E, Gurvich R, Lusky A, Barell V, Weiner M, et al. . Prevalence of Melanocytic Nevi and Freckles in Young Israeli Males: Correlation With Melanoma Incidence in Jewish Migrants: Demographic and Host Factors. Am J Epidemiol (1997) 146:78–86. doi: 10.1093/oxfordjournals.aje.a009193 - DOI - PubMed
-
- Breitbart M, Garbe C, Büttner P, Weiss J, Soyer HP, Stocker U, et al. . Ultraviolet Light Exposure, Pigmentary Traits and the Development of Melanocytic Naevi and Cutaneous Melanoma. A Case-Control Study of the German Central Malignant Melanoma Registry. . Acta Derm Venereol (1997) 77:374–8. doi: 10.2340/0001555577374378 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources